In the specialized field of biochemical research, few compounds have garnered as much interest as the exendin-4 peptide. As a researcher and enthusiast of peptide chemistry, I have spent significant time examining the molecular a 作者：X Ding·2006·被引用次数：721—Exendin-4 is a peptide agonist of the glucagon-like peptide (GLP) receptorthat promotes insulin secretion. The aim of this study was to determine whether rchitecture and functional cha Exendin-4 is defined asa peptide analog of glucagon-like peptide-1 (GLP-1) that activates its receptor and is responsible for glucose-dependent insulin release racteristics of this fascinating polypeptide. My objective here is to share my personal observations and synthesized data regarding its properties, structure, and current scientific standing, strictly for informational and research-oriented purposes.
Molecular Structure and Origins
Exendin-4 is a 39-amino acid peptide amide that was originally isolated from the oral secretions of the Gila monster (*Heloderma suspectum*). This venom protein is a remarkable example of nature’s complexity, as it functions as a high affinity glucagon-like peptide 1 (GLP-1) receptor agonist. Structurally, it is a bioactive polypeptide of 39 amino acid residues that shares significant homology with mammalian incretin hormones, yet it possesses a unique ability to resist rapid degradation.
When I analyze exendin-4, I am always struck by its specific biological activity. It acts as a peptide agonist of the glucagon-like peptide (GLP) receptor, which promotes insulin secretion through a sophisticated signaling pathway. Because it is a 39-amino acid peptide, it is often compared to its endogenous counterpart, GLP-1. While they share similarities, the synthetic form, often referred to as exenatide, has become a cornerstone in laboratory Exendin-4: From lizard to laboratoryand beyond settings for studying glucose-dependent insulin release.
Research Applications and Functional Observations
In high-quality research environments, exendin-4 is a high quality research product used to explore various cellular mechanisms. One of the most compelling aspects of this peptide is its VIP/secretin-like biological activity, which distinguishes it from other signaling molecules.
From my own review of existing literature, I have noted several key findings:
* Cellular Protection: Research suggests that exendin-4 may prevent lipotoxicity-induced apoptosis in MIN6 cells, which is a critical area of study for those interested in cellular longevity and metabolic function.
* Inhibitory Effects: There is evidence that exendin-4 inhibited the progression of DR (diabetic retinopathy) in controlled models, highlighting its potential in specialized ocular research.
* Structural Variants: Scientists often utilize exendin-(9-39)-amide, which acts as an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor, to better understand receptor kinetics and binding affinity.
Comparative Analysis: Exendin-4 vs. Synthetic Analogs
A common question in the community is how exendin-4 compares to other compounds. It is important to distinguish the parent compound from its derivatives. For instance, Ex-D3 is a promising parent peptide currently being investigated for its potential in developing superior imaging probes.
When discussing this peptide, one must also consider the exendin (Ex)-4 nomenclature. Whether we are referring to the natural venom-derived polypeptide or its synthetic iterations, the focus remains on its high affinity for the GLP-1 receptor (Kd = 136 pM). Because it is a peptide analog of glucagon-like peptide-1 (GLP-1), it serves as a gold standard for researchers attempting to map the activation of the GLP-1 receptor.
Practical Considerations for the Exendin-4, a GLP-1 receptor agonist, suppresses diabetic Researcher
For those procuring these materials for laboratory use, the Exendin-4 increases insulin sensitivity and improves glucose tolerance and iscurrently used for the treatment of Type 2 diabetes mellitusin its synthetic form market offers various purity levels. It is essential to ensure that your exendin 4 source provides comprehensive analytical data, such as HPLC and mass spectrometry results. Prices can vary significantly—I have seen high Exendin 4 (4-39) -purity samples listed for upwards of $1,213.00 depending on the ven A component of the Gila monster's venom—a peptide known asexendin-4—is being explored for new treatments for Alzheimer's disease, diabetes, dor and the specific laboratory requirements.
It is also worth noting that exendin-4 is a short incretin-mimetic peptide that requires careful handling. Its stabil Exendin-4, a glucagon-like peptide-1 analogue ity and potency make it an invaluable tool, but it is precisely this biological potency that necessitates a rigorous, evidence-based approach to all experimental designs.
Conclusion
The study of exendin-4 continues to evolve. From its discovery in the venom of *Heloderma suspectum* to its widespread use as a glucagon-like peptide 1 (GLP-1) receptor agonist, this molecule remains a testament to the intersection of evolutionary biology and modern biochemistry. As I continue to explore the nuances of this 39-amino acid sequence, I am cons Exendin-4 | Glucagon-Like Peptide 1 Receptor Agonists tantly reminded of the importance of precise, objective, and high-quality inquiry in the pursuit of scientific advancement. Whether examining its role in insulin sensitivity or its potential for future applications, exendin-4 remains a focal point for researchers worldwide.